Convergys® POC RT-PCR COVID-19 Test Cartridge

A real-time reverse transcription PCR method cartridge for detecting SARS-CoV-2 (COVID-19) nucleic acid. The cartridge provides 3-plex detection including an internal control to avoid false negative results and is compatible with the Galaxy Nano system.

A real-time reverse transcription PCR method cartridge for detecting SARS-2-CoV (COVID-19) nucleic acid with 3-plex detection including internal control.

This detection cartridge uses real-time reverse transcription PCR method for COVID-19 nucleic acid detection. COVID-19 is an acute respiratory infectious disease caused by novel coronaviruses belonging to the β genus, to which people are generally susceptible. The main source of infection is patients infected by the novel coronavirus; asymptomatic infected people can also be infectious sources. The incubation period is typically 1 to 14 days, mostly 3 to 7 days. Main manifestations include fever, fatigue, and dry cough, with nasal congestion, runny nose, sore throat, myalgia, and diarrhea occurring in some cases.

A diagnostic cartridge that provides rapid and robust detection of SARS-CoV-2 by simultaneously testing three gene targets: N, E, and ORF1ab genes.

A diagnostic kit for SARS-CoV-2 detection using real-time PCR technology. It provides comprehensive detection capability by simultaneously testing for ORF1a/b and N gene sequences with included internal controls achieving sensitivity down to 10 copies. The kit includes contamination prevention measures through dUTP and UDG enzyme incorporation. It offers convenient and rapid testing with 10 minutes of hands-on operation and completion of detection within 2.5 hours, suitable for large-scale rapid screening applications.

Molecular diagnostic kit for the detection of SARS-CoV-2 nucleic acid using real-time PCR methodology. Offers high accuracy for laboratory-based testing and epidemiological surveillance.

Molecular diagnostic kit for routine polymerase chain reaction detection of SARS-CoV-2 in clinical samples. Used in laboratory settings for confirmation of COVID-19 infection.

A real-time PCR diagnostic test for the detection of SARS-CoV-2, designed for clinical laboratory use. This in vitro diagnostic reagent enables identification of COVID-19 infections through polymerase chain reaction technology.

Real-time polymerase chain reaction kit for COVID-19 detection. This in vitro diagnostic test enables rapid molecular identification of SARS-CoV-2 in clinical specimens.

Real-time PCR kit for qualitative detection of SARS-CoV-2 (2019-nCoV) nucleic acids in respiratory specimens. Enables rapid molecular diagnosis of COVID-19 infection with high sensitivity and specificity. Suitable for clinical laboratories and diagnostic facilities requiring timely pathogen identification.

A nucleic acid test kit for qualitative detection of SARS-CoV-2 (2019-nCoV) in vitro specimens. This diagnostic test kit utilizes PCR technology for accurate identification of COVID-19 infection.

PCR-based nucleic acid detection kit for COVID-19 diagnosis using fluorescent probe technology. Designed for rapid and accurate identification of SARS-CoV-2 in clinical respiratory samples. Enables quantitative and qualitative analysis in laboratory and point-of-care settings.